NCT03654716 2025-02-14Phase 1 Study of the Dual MDM2/MDMX Inhibitor ALRN-6924 in Pediatric CancerDana-Farber Cancer InstitutePhase 1 Completed21 enrolled
NCT02130869 2017-12-22A Pilot Study of Immunotherapy Including Haploidentical NK Cell Infusion Following CD133+ Positively-Selected Autologous Hematopoietic Stem Cells in Children With High Risk Solid Tumors or LymphomasSt. Jude Children's Research HospitalPhase 1 Completed8 enrolled